Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
Trial details
- Registry ID
- NCT05068388
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast DensityNCT05068388 | ATOS | Phase 2 | Completed | 2024-06-14Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |